TAM
TXG icon

Tyers Asset Management’s 10x Genomics TXG Stock Holding History

Tyers Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$436K Buy
+8,652
New +$479K 0.01% 512

Other funds holding TXG

FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Tyers Asset Management's TXG Position: Q3 2019 in Review

Tyers Asset Management opened a new position in 10x Genomics (TXG) in Q3 2019: 8,652 shares worth $436K. The stake represents 0.01% of the portfolio and ranks #512 among its holdings.

92 funds tracked by Wall St. Rank hold TXG as of Q3 2019.

  • Tyers Asset Management held 8,652 shares of 10x Genomics worth $436K as of Q3 2019.
  • 10x Genomics was a new Tyers Asset Management position in Q3 2019.
  • 10x Genomics made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #512 holding.
  • 92 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.